As a 2022 report noted, "obesity remains the most important risk factor for the incidence and progression of osteoarthritis." According to Bliddal, the researchers launched the study to answer this question: "Would a highly effective anti-obesity medication improve KOA to a clinically meaningful degree?" Other studies had tackled the question with inconsistent results, he said
David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, et al
Both medications are once-weekly injectable treatments used for weight management, but they are not the same
Glutathione plays a role in protecting neurons from oxidative damage, supporting cognitive clarity, and maintaining vascular function through improved endothelial health
We used to call Ozempic face facial wasting